Etebari Faezeh, Rezvani Mohammad Ebrahim, Khosravi Sahar, Izadi Mahin, Mangoli Esmat
Department of Physiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Int Urol Nephrol. 2025 May 8. doi: 10.1007/s11255-025-04540-z.
Sperm motility is a key indicator of male fertility. Decreased motility, or asthenozoospermia, highlights the need for understanding male fertility challenges. This study was designed to evaluate the effects of in vitro use of follicle-stimulating hormone (FSH) on various sperm parameters, sperm DNA integrity, and mitochondrial membrane potential. Semen samples were obtained from 20 asthenozoospermic men. Each sample was divided into control and case groups. In the case group, samples were incubated with FSH at 30 mIU/mL for 1 h, while in the control group, the samples were incubated for 1 h without treatment. Sperm parameters, DNA fragmentation, and mitochondrial membrane potential were assessed in the two groups based on WHO 2021 criteria. Progressive motility and rapid progressive motility were higher in the case group compared to the control. However, FSH did not have a significant effect on morphology, viability, DNA fragmentation, or mitochondrial membrane potential in either group. In conclusion, FSH effectively enhanced sperm motility without compromising sperm DNA integrity or mitochondrial membrane potential (MMP). Therefore, FSH can be recommended as a safe and effective option for sperm selection in patients with asthenozoospermia.
精子活力是男性生育能力的关键指标。活力下降,即弱精子症,凸显了理解男性生育挑战的必要性。本研究旨在评估体外使用促卵泡激素(FSH)对各种精子参数、精子DNA完整性和线粒体膜电位的影响。从20名弱精子症男性中获取精液样本。每个样本分为对照组和病例组。病例组样本用30 mIU/mL的FSH孵育1小时,而对照组样本未经处理孵育1小时。根据世界卫生组织2021年标准对两组的精子参数、DNA片段化和线粒体膜电位进行评估。与对照组相比,病例组的前向运动和快速前向运动更高。然而,FSH对两组的形态、活力、DNA片段化或线粒体膜电位均无显著影响。总之,FSH有效地提高了精子活力,而不损害精子DNA完整性或线粒体膜电位(MMP)。因此,FSH可被推荐为弱精子症患者精子筛选的安全有效选择。